Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, NO.23 Pingjiang Road, Hexi District, Tianjin, CN, 300211, People's Republic of China.
BMC Urol. 2024 Aug 21;24(1):174. doi: 10.1186/s12894-024-01561-1.
To investigate the safety of short-term stenting following flexible ureteroscopic lithotripsy (fURL) for patients without preoperative stents. Retaining double-J stent for 1-2 weeks after fURL is a common practice. At present, data on short-term stenting after non-pre-stented fURL is still lacking.
182 patients who met inclusion criteria were retrospectively divided into the 2-days group (2-day removal, 76 cases) and the 1-week group (1-week removal, 106 cases). The study endpoint was stent-associated adverse symptoms assessed by follow-up and completed validated questionnaires on postoperative days (POD) 7 and 12. A postoperative imaging review was performed 1 month after the surgery.
No statistical differences were found in the patients' demographic and stone-related characteristics. The 2-days group showed fewer urinary tract symptoms and lower scores on the ureteral stent symptom questionnaire on POD 7: less backache during urination (p = 0.004), less hematuria (p = 0.031), less frequent urination (p = 0.004), lower urinary symptoms index (p < 0.001), lower general health index (p < 0.001), and lower performance index (p < 0.001). There were no significant differences in fever (p = 0.372), visual analogue scale score (p = 0.760), and painkiller requirements (p = 0.160) on POD 7. The average general health score and work performance score remained significantly higher in the 1-week group patients at 5 days after removal compared to the 2-days group patients at 5 days after removal. (p < 0.001, p = 0.005). Five patients in the 2-days group and 15 patients in the 1-week group returned to the emergency department for additional treatments. No patient required rehospitalization. Stone-free rates were 85.5% in the 2-days group and 80.2% in the 1-week group (p = 0.499), respectively, and none of the patients got aggravating hydronephrosis.
Compared to the common 1-week stent removal option, short-term stenting after non-pre-stented fURL is safe, which can enhance the patient's quality of life.
探讨无术前支架的输尿管软镜碎石术后短期支架(fURL)的安全性。fURL 后留置双 J 支架 1-2 周是一种常见的做法。目前,关于非预支架 fURL 后短期支架的数据仍然缺乏。
回顾性纳入符合纳入标准的 182 例患者,分为 2 天组(2 天取出,76 例)和 1 周组(1 周取出,106 例)。研究终点为术后第 7 天和第 12 天通过随访和完成验证后的问卷评估支架相关不良症状。术后 1 个月进行术后影像学复查。
两组患者的人口统计学和结石相关特征无统计学差异。2 天组在术后第 7 天的尿路上尿路症状和输尿管支架症状问卷评分较低:排尿时腰痛较少(p=0.004),血尿较少(p=0.031),尿频较少(p=0.004),下尿路症状指数较低(p<0.001),一般健康指数较低(p<0.001),活动指数较低(p<0.001)。术后第 7 天,发热(p=0.372)、视觉模拟评分(p=0.760)和止痛药需求(p=0.160)无显著差异。与 2 天组相比,1 周组在取出支架后 5 天的一般健康评分和工作表现评分仍明显较高。(p<0.001,p=0.005)。2 天组有 5 例患者和 1 周组有 15 例患者因其他治疗返回急诊室。没有患者需要再次住院。2 天组和 1 周组的无石率分别为 85.5%和 80.2%(p=0.499),且无患者出现加重的肾积水。
与常见的 1 周支架取出方案相比,非预支架 fURL 后短期支架是安全的,可以提高患者的生活质量。